Olema Oncology reels in $54m Series A
San Francisco-based Olema Oncology, a biopharmaceutical company, has raised $54 million in Series B financing.
San Francisco-based Olema Oncology, a biopharmaceutical company, has raised $54 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
